Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Theralase on Global TV

<< Previous

Bullboard Posts

Next >>

Comment by BencrosMumon Jan 27, 2021 7:12pm

158 Views

Post# 32404185

RE:RE:RE:Theralase on Global TV

I think what is mentioned is Steriwave

good ears though!!! It won't be long till we actually start hearing theralase in the news though!!!

iknowsmthing wrote:

Oops now I'm not so sure. If it's Theralase or a different company being mentioned? If it's not Theralase mentioned around the 1 minute mark....my apologies.

video attached. https://globalnews.ca/video/7603965/can-light-therapy-treat-early-stages-of-covid-19

Can light therapy treat early stages of COVID-19?

There’s research underway at Sunnybrook Research Institute focused on whether a light therapy called photodisinfection can be used to prevent or treat the early stages of COVID-19. The study team is still looking for people who have been recently diagnosed with COVID-19 (symptomatic or asymptomatic) to participate in the study.